Results 251 to 260 of about 1,080,879 (306)
Some of the next articles are maybe not open access.
Mechanical Activation of Pharmaceutical Systems
Pharmaceutical Research, 1985Mechanical activation has become a phenomenon of general significance in pharmaceutics. This report describes the extent of activation induced by relevant processes. With the use of the Eyring equation the transformation of structurally stored energy into chemical energy and the implied free enthalpy as well as the excess free enthalpy (activity) were ...
R, Hüttenrauch, S, Fricke, P, Zielke
openaire +2 more sources
Prioritizing Pharmaceutical Activities
Journal of Pharmacy Practice, 2012Objectives:The primary objective was to examine the consistency of prioritization decisions made by pharmacy residents in a simulated environment where the available resources are constrained. Secondary objectives were to rank the factors that influenced their prioritization and to compare the residents’ results with those of Canadian pharmacy leaders ...
Sophie, Renet +3 more
openaire +2 more sources
Active Pharmaceutical Ingredients
2004INTRODUCTION Active Pharmaceutical Ingredients (APIs) play an important role in the drug product industry. The most obvious contribution is that the API is the active ingredient that makes a drug product effective and provides the pharmacological activity of any drug product or dosage form.
Lih-Yang Lin, Edward Cohen
+4 more sources
Pharmaceutical Strategies for Activating Sirtuins
Current Pharmaceutical Design, 2009The sirtuins are protein modifying enzymes widely distributed in all forms of life. The sirtuins are principally NAD(+)-dependent protein acetyl-lysine deacetylases that reverse acetyl-modifications of proteins. The sirtuins are implicated in a variety of adaptations to reduced nutritional intake, and increase lifespan in several model organisms, such ...
openaire +2 more sources
On Innovative Activity in Pharmaceutical Industry
Vestnik NSUEM, 2021The article provides with different approaches to the assessment of pharmaceutical manufacturers’ innovation activity. The peculiarities of pharmaceutical industry product that can be characterized as innovative are taken into consideration. Special attention has been given to the pharmaceutical industry peculiarities originating from differentiation ...
M. I. Berkovich, A. Yu. Volin
openaire +1 more source
Investigation of active pharmaceutical ingredient loss in pharmaceutical compounding of capsules
Journal of Pharmaceutical and Biomedical Analysis, 2014Pharmaceutical compounding of capsules is still an important corner stone in today's health care. It allows for a more patient specific treatment plan as opposed to the "one size fits all"-approach, used by the pharmaceutical industry when producing fixed dose finished drug products. However, loss of active pharmaceutical ingredient (API) powder during
Matthias, D'Hondt +8 more
openaire +2 more sources
Asymmetric Synthesis of Active Pharmaceutical Ingredients
ChemInform, 2006AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Vittorio, Farina +3 more
openaire +2 more sources
Pharmaceutical removal by the activated carbon process
Water Quality Research Journal, 2013The adsorption of some major pharmaceutical products (sulfamethoxazole, caffeine, iopromide and carbamazepine) in water was evaluated using four types of activated carbon, three powdered activated carbon (PAC) and one fluidized, coagulated and flocculated activated carbon (FAC) extracted from a Carboplus®P pilot.
Piel, Stéphanie +4 more
openaire +2 more sources
Manufacturing Peptides as Active Pharmaceutical Ingredients
Future Medicinal Chemistry, 2009Today, there are more than 40 peptides on the pharmaceutical world market and more than 100 in several clinical phases. Although in the past the pharmaceutical industries had reduced their interest in peptides research, in recent decades, they have rekindled their interest in peptides as a result of contemporary novel technological accomplishments ...
Aikaterini A, Zompra +3 more
openaire +2 more sources
Treatment of Tuberculosis: Use of Active Pharmaceuticals
Recent Patents on Anti-Infective Drug Discovery, 2008Tuberculosis (TB) is a highly infectious disease caused by several species of mycobacteria. Multi drug resistant strains of mycobacteria leading to the increase of patient world wide. There is an urgent need for new effective antimicrobial agent to replace those currently in use because of highly toxic.
Abdus, Samad +3 more
openaire +2 more sources